ScreenerHero

ABS Arctic Bioscience AS

OSL · NO · Healthcare · Biotechnology · arctic-bioscience.com
2.800NOK0.00%Mkt Cap: 7.06M $P/E: —

Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europ…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap7.06M USD
Enterprise Value14.55M USD
Revenue (TTM)4.58M USD
Gross Profit1.03M USD
Net Income (TTM)-3.84M USD
Revenue/Share1.81 NOK
Last Price2.800 NOK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees19
CountryNO
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-14.00
PEG—
EV/EBITDA-5.19
EV/Revenue3.18
P/S1.54
P/B0.49
EPS (TTM)-1.48
EPS (Forward)-0.20
52W Range
2.33025% of range4.200
52W High4.200 NOK
52W Low2.330 NOK
Profitability
Gross Margin27.54%
Oper. Margin-57.36%
EBITDA Margin-61.22%
Profit Margin-102.32%
ROE-23.65%
ROA-14.41%
Growth
Revenue Growth33.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.12M USD
CapEx (TTM)2.13M USD
FCF Margin-33.12%
FCF Yield-21.48%
Net Debt7.50M USD
Net Debt/EBITDA-2.68
Balance Sheet
Debt/Equity0.37
Current Ratio0.60
Quick Ratio0.21
Book Value/Sh5.77 NOK
Cash/Share0.0050 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 NOK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.26.96M
Float12.29M
Insiders51.23%
Institutions1.44%
Technical
SMA 502.826 (-0.9%)
SMA 2003.196 (-12.4%)
Beta1.07
S&P 52W Chg14.58%
Avg Vol (30d)10.48K
Avg Vol (10d)2.86K
Technical Indicators
RSI (14)51.2
MACD-0.0388
MACD Signal-0.0494
MACD Hist.+0.0106
BB Upper2.882 NOK
BB Middle2.739 NOK
BB Lower2.595 NOK
BB Width10.50%
ATR (14)0.1830 NOK
Vol Ratio (20d)0.00x